文献速递消化、代谢与肾脏急症

受circUQCRC2调控的miR-208a-3p通过抑制CELF2介导的肾小管上皮细胞凋亡、炎症和铁死亡减轻缺血/再灌注诱导的急性肾损伤

miR-208a-3p regulated by circUQCRC2 suppresses ischemia/reperfusion-induced acute kidney injury by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis.
PubMed 文献 · Shock · 2024-04-26
一句话结论细胞与小鼠实验显示,circUQCRC2下调miR-208a-3p,miR-208a-3p靶向抑制CELF2,从而减轻缺血/再灌注诱导的肾小管上皮细胞凋亡、炎症和铁死亡。

本研究在缺氧/复氧处理的肾小管上皮细胞HK-2和缺血/再灌注诱导的AKI小鼠模型中,探讨miR-208a-3p的作用及机制。结果发现两种AKI模型中miR-208a-3p表达受抑,而CELF2和circUQCRC2表达升高;上调miR-208a-3p或沉默circUQCRC2可提高H/R刺激HK-2细胞活力、降低促炎因子(TNF-α、IL-1β、IL-6)水平、减少凋亡及Fe2+和活性氧含量、升高GPX4和SLC7A11表达、降低ACSL4表达。小鼠模型中miR-208a-3p改善肾功能并减轻肾损伤、凋亡、炎症和铁死亡。CELF2是miR-208a-3p的靶基因,受circUQCRC2负向调控,过表达CELF2可阻断上述保护效应。结论提示miR-208a-3p受circUQCRC2调控,通过抑制CELF2介导的肾小管上皮细胞凋亡、炎症和铁死亡减轻I/R诱导的AKI,为I/R诱导的AKI提供了潜在治疗靶点。

要点

  • 在H/R刺激的HK-2细胞中,上调miR-208a-3p或沉默circUQCRC2可提高细胞活力、降低TNF-α、IL-1β和IL-6水平、减少凋亡及Fe2+和活性氧含量。
  • 在I/R诱导的AKI小鼠模型中,miR-208a-3p可改善肾功能,减轻肾损伤、凋亡、炎症和铁死亡。
  • CELF2是miR-208a-3p的靶基因,受circUQCRC2负向调控;过表达CELF2可阻断miR-208a-3p上调或circUQCRC2沉默对H/R处理HK-2细胞的保护作用。
  • circUQCRC2下调对H/R损伤细胞的效应可被miR-208a-3p抑制剂逆转。
  • 两种AKI模型中miR-208a-3p表达受抑,而CELF2和circUQCRC2表达升高。

适用人群与场景

  • 缺氧/复氧(H/R)暴露的肾小管上皮细胞HK-2
  • 缺血/再灌注(I/R)诱导的AKI小鼠模型

研究设计与关键结果

  • 研究类型为细胞与小鼠实验:采用H/R暴露的HK-2细胞和I/R诱导的AKI小鼠,通过功能获得与缺失方法研究miR-208a-3p的作用与机制。
  • 两种AKI模型中miR-208a-3p表达受抑,CELF2和circUQCRC2表达升高。
  • 在H/R刺激的HK-2细胞中,上调miR-208a-3p或沉默circUQCRC2可提高细胞活力、降低促炎因子(TNF-α、IL-1β、IL-6)水平、减少凋亡及Fe2+和活性氧含量、升高GPX4和SLC7A11表达、降低ACSL4表达。
  • 在I/R诱导的AKI小鼠模型中,miR-208a-3p通过减轻肾损伤、凋亡、炎症和铁死亡改善肾功能。
  • CELF2是miR-208a-3p的靶基因,受circUQCRC2负向调控;过表达CELF2可阻断miR-208a-3p上调或circUQCRC2沉默对H/R处理HK-2细胞的作用。
  • circUQCRC2下调对H/R损伤细胞的效应可被miR-208a-3p抑制剂逆转。

证据类型、等级与局限

  • 证据类型:细胞实验与小鼠在体实验(基础研究)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为本研究为I/R诱导的AKI提供了潜在治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background : Acute kidney injury (AKI) is a prevalent clinical syndrome with persistent kidney dysfunction. Renal ischemia/reperfusion (I/R) injury is a major cause of AKI. miR-208a-3p overexpression attenuated myocardial I/R injury. This study aims to investigate the role and mechanism of miR-208a-3p in I/R-induced AKI. Methods : AKI models were established using hypoxia/reoxygenation (H/R)-exposed tubule epithelial cell HK-2 and I/R-induced mice. The function and mechanism of miR-208a-3p were investigated by gain- or loss-of-function methods using real-time PCR, CCK-8, flow cytometry, ELISA, western blot, hematoxylin-eosin staining, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, detection of Fe 2+ , reactive oxygen species, blood urea nitrogen and creatinine, and luciferase reporter assay. Results : miR-208a-3p expression was suppressed, while the expression of CELF2 and circular RNA ubiquinol-cytochrome c reductase core protein 2 (circUQCRC2) was increased in both AKI models. miR-208a-3p upregulation or circUQCRC2 silencing increased the viability, decreased the levels of proinflammatory cytokines (TNF-α, IL-1β, and IL-6), reduced apoptosis and contents of Fe 2+ and reactive oxygen species, elevated expression of GPX4 and SLC7A11, and reduced ACSL4 expression in H/R-stimulated HK-2 cells. In addition, miR-208a-3p improved kidney function by alleviating renal injury, apoptosis, inflammation, and ferroptosis in AKI mouse model. CELF2 was a target gene of miR-208a-3p, which was negatively modulated by circUQCRC2. Overexpression of CELF2 blocked the function of miR-208a-3p upregulation or circUQCRC2 silencing on H/R-treated HK-2 cells. Moreover, the effects of circUQCRC2 downregulation on H/R-injured cells were also reversed by miR-208a-3p inhibitor. Conclusions : miR-208a-3p regulated by circUQCRC2 could attenuate I/R-induced AKI by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis. This study provides potential therapeutic targets for I/R-induced AKI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Huang P, Meng L, Pang J, et al. miR-208a-3p regulated by circUQCRC2 suppresses ischemia/reperfusion-induced acute kidney injury by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis. Shock. 2024. PMID: 38664873. doi:10.1097/SHK.0000000000002339

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。